Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Jul 30;309(6950):321–324. doi: 10.1136/bmj.309.6950.321

Treatment of anxiety.

M Lader 1
PMCID: PMC2540896  PMID: 8086871

Full text

PDF
321

Images in this article

324p324-a
on p.324

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curran H. V. Benzodiazepines, memory and mood: a review. Psychopharmacology (Berl) 1991;105(1):1–8. doi: 10.1007/BF02316856. [DOI] [PubMed] [Google Scholar]
  2. Dietch J. T., Jennings R. K. Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psychiatry. 1988 May;49(5):184–188. [PubMed] [Google Scholar]
  3. Donnan P., Hutchinson A., Paxton R., Grant B., Firth M. Self-help materials for anxiety: a randomized controlled trial in general practice. Br J Gen Pract. 1990 Dec;40(341):498–501. [PMC free article] [PubMed] [Google Scholar]
  4. Durham R. C., Allan T. Psychological treatment of generalised anxiety disorder. A review of the clinical significance of results in outcome studies since 1980. Br J Psychiatry. 1993 Jul;163:19–26. doi: 10.1192/bjp.163.1.19. [DOI] [PubMed] [Google Scholar]
  5. Durham R. C., Turvey A. A. Cognitive therapy vs behaviour therapy in the treatment of chronic general anxiety. Behav Res Ther. 1987;25(3):229–234. doi: 10.1016/0005-7967(87)90051-9. [DOI] [PubMed] [Google Scholar]
  6. Fitton A., Faulds D., Goa K. L. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness. Drugs. 1992 Apr;43(4):561–596. doi: 10.2165/00003495-199243040-00009. [DOI] [PubMed] [Google Scholar]
  7. Ghoneim M. M., Mewaldt S. P. Benzodiazepines and human memory: a review. Anesthesiology. 1990 May;72(5):926–938. [PubMed] [Google Scholar]
  8. Raskin M., Bali L. R., Peeke H. V. Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety. Arch Gen Psychiatry. 1980 Jan;37(1):93–97. doi: 10.1001/archpsyc.1980.01780140095011. [DOI] [PubMed] [Google Scholar]
  9. Rickels K., Downing R., Schweizer E., Hassman H. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry. 1993 Nov;50(11):884–895. doi: 10.1001/archpsyc.1993.01820230054005. [DOI] [PubMed] [Google Scholar]
  10. Serfaty M., Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry. 1993 Sep;163:386–393. doi: 10.1192/bjp.163.3.386. [DOI] [PubMed] [Google Scholar]
  11. Sheehan D. V., Ballenger J., Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry. 1980 Jan;37(1):51–59. doi: 10.1001/archpsyc.1980.01780140053006. [DOI] [PubMed] [Google Scholar]
  12. Tiller J. W., Schweitzer I. Benzodiazepines. Depressants or antidepressants? Drugs. 1992 Aug;44(2):165–169. doi: 10.2165/00003495-199244020-00001. [DOI] [PubMed] [Google Scholar]
  13. Tyrer P. Current status of beta-blocking drugs in the treatment of anxiety disorders. Drugs. 1988 Dec;36(6):773–783. doi: 10.2165/00003495-198836060-00006. [DOI] [PubMed] [Google Scholar]
  14. Tyrer P., Seivewright N., Murphy S., Ferguson B., Kingdon D., Barczak P., Brothwell J., Darling C., Gregory S., Johnson A. L. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet. 1988 Jul 30;2(8605):235–240. doi: 10.1016/s0140-6736(88)92535-4. [DOI] [PubMed] [Google Scholar]
  15. Westenberg H. G., den Boer J. A. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacol Bull. 1989;25(1):119–123. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES